[{:genegraph.annotate/format :clinvar-raw,
  :genegraph.sink.event/key "trait_38576_2019-07-01",
  :genegraph.sink.event/value
  "{\"release_date\":\"2019-07-01\",\"event_type\":\"create\",\"content\":{\"entity_type\":\"trait\",\"clingen_version\":0,\"name\":\"Rare genetic deafness\",\"type\":\"Disease\",\"xrefs\":[\"{\\\"db\\\":\\\"Orphanet\\\",\\\"id\\\":\\\"96210\\\"}\",\"{\\\"db\\\":\\\"Orphanet\\\",\\\"id\\\":\\\"96210\\\",\\\"ref_field\\\":\\\"name\\\"}\"],\"keywords\":[],\"attribute_content\":[],\"medgen_id\":\"CN826980\",\"id\":\"38576\",\"alternate_symbols\":[],\"alternate_names\":[]}}",
  :genegraph.sink.stream/timestamp 1660853039062,
  :genegraph.sink.stream/topic "clinvar-raw",
  :genegraph.sink.stream/partition 0,
  :genegraph.sink.stream/offset 1971836,
  :genegraph.annotate/producer-topic :test-public-v1}
 {:genegraph.annotate/format :clinvar-raw,
  :genegraph.sink.event/key "trait_939_2020-05-06",
  :genegraph.sink.event/value
  "{\"release_date\":\"2020-05-06\",\"event_type\":\"update\",\"content\":{\"entity_type\":\"trait\",\"content\":\"{\\\"Citation\\\":[{\\\"@Abbrev\\\":\\\"GeneReviews\\\",\\\"@Type\\\":\\\"review\\\",\\\"ID\\\":[{\\\"$\\\":\\\"20301388\\\",\\\"@Source\\\":\\\"PubMed\\\"},{\\\"$\\\":\\\"NBK1209\\\",\\\"@Source\\\":\\\"BookShelf\\\"}]},{\\\"@Abbrev\\\":\\\"GeneReviews\\\",\\\"@Type\\\":\\\"review\\\",\\\"ID\\\":[{\\\"$\\\":\\\"20301607\\\",\\\"@Source\\\":\\\"PubMed\\\"},{\\\"$\\\":\\\"NBK1434\\\",\\\"@Source\\\":\\\"BookShelf\\\"}]},{\\\"@Abbrev\\\":\\\"ACMG, 2002\\\",\\\"@Type\\\":\\\"practice guideline\\\",\\\"ID\\\":{\\\"$\\\":\\\"3110944\\\",\\\"@Source\\\":\\\"pmc\\\"}}]}\",\"clingen_version\":0,\"symbol\":\"DFNA2A\",\"name\":\"Autosomal dominant nonsyndromic deafness 2A\",\"type\":\"Disease\",\"xrefs\":[\"{\\\"db\\\":\\\"MONDO\\\",\\\"id\\\":\\\"MONDO:0010817\\\"}\",\"{\\\"db\\\":\\\"OMIM\\\",\\\"id\\\":\\\"600101\\\",\\\"type\\\":\\\"MIM\\\"}\",\"{\\\"db\\\":\\\"Orphanet\\\",\\\"id\\\":\\\"90635\\\"}\",\"{\\\"db\\\":\\\"Genetic Alliance\\\",\\\"id\\\":\\\"DFNA+2+Nonsyndromic+Hearing+Loss/8212\\\",\\\"ref_field\\\":\\\"alternate_names\\\",\\\"ref_field_element\\\":\\\"DFNA 2 Nonsyndromic Hearing Loss\\\"}\",\"{\\\"db\\\":\\\"MONDO\\\",\\\"id\\\":\\\"MONDO:0010817\\\",\\\"ref_field\\\":\\\"name\\\"}\",\"{\\\"db\\\":\\\"GeneReviews\\\",\\\"id\\\":\\\"NBK1209\\\",\\\"ref_field\\\":\\\"public_definition\\\"}\",\"{\\\"db\\\":\\\"OMIM\\\",\\\"id\\\":\\\"600101\\\",\\\"type\\\":\\\"MIM\\\",\\\"ref_field\\\":\\\"symbol\\\"}\"],\"keywords\":[],\"attribute_content\":[],\"medgen_id\":\"C2677637\",\"id\":\"939\",\"alternate_symbols\":[],\"public_definition\":\"DFNA2 nonsyndromic hearing loss is characterized by symmetric, predominantly high-frequency sensorineural hearing loss (SNHL) that is progressive across all frequencies. At younger ages, hearing loss tends to be mild in the low frequencies and moderate in the high frequencies; in older persons, the hearing loss is moderate in the low frequencies and severe to profound in the high frequencies. Although the hearing impairment is often detected during routine hearing assessment of a school-age child, it is likely that hearing is impaired from birth, especially at high frequencies. Most affected persons initially require hearing aids to assist with sound amplification between ages ten and 40 years. By age 70 years, all persons with DFNA2 nonsyndromic hearing loss have severe-to-profound hearing impairment.\",\"alternate_names\":[\"DFNA 2 Nonsyndromic Hearing Loss\",\"Deafness, autosomal dominant 2A\"]}}",
  :genegraph.sink.stream/timestamp 1660855603320,
  :genegraph.sink.stream/topic "clinvar-raw",
  :genegraph.sink.stream/partition 0,
  :genegraph.sink.stream/offset 17918505,
  :genegraph.annotate/producer-topic :test-public-v1}
 {:genegraph.annotate/format :clinvar-raw,
  :genegraph.sink.event/key "trait_9544_2020-06-22",
  :genegraph.sink.event/value
  "{\"release_date\":\"2020-06-22\",\"event_type\":\"update\",\"content\":{\"entity_type\":\"trait\",\"content\":\"{\\\"Citation\\\":{\\\"@Abbrev\\\":\\\"ACMG, 2002\\\",\\\"@Type\\\":\\\"practice guideline\\\",\\\"ID\\\":{\\\"$\\\":\\\"3110944\\\",\\\"@Source\\\":\\\"pmc\\\"}}}\",\"clingen_version\":0,\"name\":\"Nonsyndromic hearing loss and deafness\",\"type\":\"Disease\",\"xrefs\":[\"{\\\"db\\\":\\\"MONDO\\\",\\\"id\\\":\\\"MONDO:0019497\\\"}\",\"{\\\"db\\\":\\\"Orphanet\\\",\\\"id\\\":\\\"87884\\\"}\",\"{\\\"db\\\":\\\"Orphanet\\\",\\\"id\\\":\\\"87884\\\",\\\"ref_field\\\":\\\"alternate_names\\\",\\\"ref_field_element\\\":\\\"Non-syndromic genetic deafness\\\"}\",\"{\\\"db\\\":\\\"MONDO\\\",\\\"id\\\":\\\"MONDO:0019497\\\",\\\"ref_field\\\":\\\"alternate_names\\\",\\\"ref_field_element\\\":\\\"Nonsyndromic genetic deafness\\\"}\",\"{\\\"db\\\":\\\"Office of Rare Diseases\\\",\\\"id\\\":\\\"6410\\\",\\\"ref_field\\\":\\\"gard_id\\\"}\",\"{\\\"db\\\":\\\"Genetics Home Reference\\\",\\\"id\\\":\\\"nonsyndromic-hearing-loss\\\",\\\"ref_field\\\":\\\"public_definition\\\"}\"],\"keywords\":[],\"attribute_content\":[],\"medgen_id\":\"CN043648\",\"id\":\"9544\",\"alternate_symbols\":[],\"gard_id\":\"6410\",\"public_definition\":\"Nonsyndromic hearing loss is a partial or total loss of hearing that is not associated with other signs and symptoms. In contrast, syndromic hearing loss occurs with signs and symptoms affecting other parts of the body.Nonsyndromic hearing loss can be classified in several different ways. One common way is by the condition's pattern of inheritance: autosomal dominant (DFNA), autosomal recessive (DFNB), X-linked (DFNX), or mitochondrial (which does not have a special designation). Each of these types of hearing loss includes multiple subtypes. DFNA, DFNB, and DFNX subtypes are numbered in the order in which they were first described. For example, DFNA1 was the first type of autosomal dominant nonsyndromic hearing loss to be identified.The characteristics of nonsyndromic hearing loss vary among the different types. Hearing loss can affect one ear (unilateral) or both ears (bilateral). Degrees of hearing loss range from mild (difficulty understanding soft speech) to profound (inability to hear even very loud noises). The term \\\"deafness\\\" is often used to describe severe-to-profound hearing loss. Hearing loss can be stable, or it may be progressive, becoming more severe as a person gets older. Particular types of nonsyndromic hearing loss show distinctive patterns of hearing loss. For example, the loss may be more pronounced at high, middle, or low tones.Most forms of nonsyndromic hearing loss are described as sensorineural, which means they are associated with a permanent loss of hearing caused by damage to structures in the inner ear. The inner ear processes sound and sends the information to the brain in the form of electrical nerve impulses. Less commonly, nonsyndromic hearing loss is described as conductive, meaning it results from changes in the middle ear. The middle ear contains three tiny bones that help transfer sound from the eardrum to the inner ear. Some forms of nonsyndromic hearing loss, particularly a type called DFNX2, involve changes in both the inner ear and the middle ear. This combination is called mixed hearing loss.Depending on the type, nonsyndromic hearing loss can become apparent at any time from infancy to old age. Hearing loss that is present before a child learns to speak is classified as prelingual or congenital. Hearing loss that occurs after the development of speech is classified as postlingual.\",\"alternate_names\":[\"Non-syndromic genetic deafness\",\"Nonsyndromic genetic deafness\"]}}",
  :genegraph.sink.stream/timestamp 1660856057396,
  :genegraph.sink.stream/topic "clinvar-raw",
  :genegraph.sink.stream/partition 0,
  :genegraph.sink.stream/offset 21614807,
  :genegraph.annotate/producer-topic :test-public-v1}
 {:genegraph.annotate/format :clinvar-raw,
  :genegraph.sink.event/key "trait_set_9568_2019-07-01",
  :genegraph.sink.event/value
  "{\"release_date\":\"2019-07-01\",\"event_type\":\"create\",\"content\":{\"id\":\"9568\",\"type\":\"Disease\",\"trait_ids\":[\"9544\"],\"entity_type\":\"trait_set\",\"clingen_version\":0}}",
  :genegraph.sink.stream/timestamp 1660853040658,
  :genegraph.sink.stream/topic "clinvar-raw",
  :genegraph.sink.stream/partition 0,
  :genegraph.sink.stream/offset 1990679,
  :genegraph.annotate/producer-topic :test-public-v1}
 {:genegraph.annotate/format :clinvar-raw,
  :genegraph.sink.event/key "trait_set_40993_2019-07-01",
  :genegraph.sink.event/value
  "{\"release_date\":\"2019-07-01\",\"event_type\":\"create\",\"content\":{\"id\":\"40993\",\"type\":\"Disease\",\"trait_ids\":[\"38576\"],\"entity_type\":\"trait_set\",\"clingen_version\":0}}",
  :genegraph.sink.stream/timestamp 1660853040599,
  :genegraph.sink.stream/topic "clinvar-raw",
  :genegraph.sink.stream/partition 0,
  :genegraph.sink.stream/offset 1985922,
  :genegraph.annotate/producer-topic :test-public-v1}
 {:genegraph.annotate/format :clinvar-raw,
  :genegraph.sink.event/key "trait_set_1730_2019-07-01",
  :genegraph.sink.event/value
  "{\"release_date\":\"2019-07-01\",\"event_type\":\"create\",\"content\":{\"id\":\"1730\",\"type\":\"Disease\",\"trait_ids\":[\"939\"],\"entity_type\":\"trait_set\",\"clingen_version\":0}}",
  :genegraph.sink.stream/timestamp 1660853040586,
  :genegraph.sink.stream/topic "clinvar-raw",
  :genegraph.sink.stream/partition 0,
  :genegraph.sink.stream/offset 1984769,
  :genegraph.annotate/producer-topic :test-public-v1}
 {:genegraph.annotate/format :clinvar-raw,
  :genegraph.sink.event/key "trait_set_1730_2019-07-01",
  :genegraph.sink.event/value
  "{\"release_date\":\"2019-07-01\",\"event_type\":\"create\",\"content\":{\"id\":\"1730\",\"type\":\"Disease\",\"trait_ids\":[\"939\"],\"entity_type\":\"trait_set\",\"clingen_version\":0}}",
  :genegraph.sink.stream/timestamp 1660853040586,
  :genegraph.sink.stream/topic "clinvar-raw",
  :genegraph.sink.stream/partition 0,
  :genegraph.sink.stream/offset 1984769,
  :genegraph.annotate/producer-topic :test-public-v1}
 {:genegraph.annotate/format :clinvar-raw,
  :genegraph.sink.event/key
  "clinical_assertion_SCV000840524_2021-05-01",
  :genegraph.sink.event/value
  "{\"release_date\":\"2021-05-01\",\"event_type\":\"update\",\"content\":{\"variation_id\":\"6241\",\"entity_type\":\"clinical_assertion\",\"variation_archive_id\":\"VCV000006241\",\"submitter_id\":\"506744\",\"date_last_updated\":\"2021-04-27\",\"interpretation_comments\":[\"{\\\"text\\\":\\\"The p.Gly285Ser variant in the KCNQ4 gene was absent from the Genome Aggregation Database (http://gnomad.broadinstitute.org) (PM2). The p.Gly285Ser variant has been reported to segregate with hearing loss in at least 16 family members (PP1_S; PMIDs: 10025409, 25116015). The variant meets PM2 and has been observed in at least 2 affected probands (PS4_P, PMID: 10025409, Partners LMM internal data SCV000198442.4). A different pathogenic missense variant (p.Gly285Cys) has been previously identified at this codon of KCNQ4 which may indicate that this residue is critical to the function of the protein (PM5; ClinVar Variation ID 6244, PMID: 10369879). Furthermore, the variant is in a location that has been defined by the ClinGen Hearing Loss Expert Panel to be a mutational hotspot or domain of KCNQ4 (PM1; PMID: 23717403; https://www.uniprot.org/uniprot/P56696). A functional study demonstrates that this variant may impact protein function (PS3_P; PMID: 10025409, 18786918). In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant nonsyndromic hearing loss based on the ACMG/AMP criteria applied as specified by the Hearing Loss Expert Panel: PM2, PP1_S, PS4_P, PM5, PM1, PS3_P.\\\"}\"],\"interpretation_description\":\"Pathogenic\",\"trait_set_id\":\"9568\",\"internal_id\":\"1638706\",\"content\":\"{\\\"@FDARecognizedDatabase\\\":\\\"true\\\",\\\"AttributeSet\\\":[{\\\"Attribute\\\":{\\\"$\\\":\\\"Autosomal dominant inheritance\\\",\\\"@Type\\\":\\\"ModeOfInheritance\\\"}},{\\\"Attribute\\\":{\\\"$\\\":\\\"ClinGen HL ACMG Specifications v1\\\",\\\"@Type\\\":\\\"AssertionMethod\\\"},\\\"Citation\\\":{\\\"URL\\\":{\\\"$\\\":\\\"https://submit.ncbi.nlm.nih.gov/ft/byid/vroiax8b/hearing_loss_acmg_specifications_v1_2018.pdf\\\"}}}],\\\"ClinVarSubmissionID\\\":{\\\"@localKeyIsSubmitted\\\":\\\"1\\\"},\\\"Interpretation\\\":{\\\"Citation\\\":[{\\\"ID\\\":{\\\"$\\\":\\\"8035838\\\",\\\"@Source\\\":\\\"PubMed\\\"}},{\\\"ID\\\":{\\\"$\\\":\\\"18786918\\\",\\\"@Source\\\":\\\"PubMed\\\"}},{\\\"ID\\\":{\\\"$\\\":\\\"25116015\\\",\\\"@Source\\\":\\\"PubMed\\\"}},{\\\"ID\\\":{\\\"$\\\":\\\"10025409\\\",\\\"@Source\\\":\\\"PubMed\\\"}},{\\\"ID\\\":{\\\"$\\\":\\\"10369879\\\",\\\"@Source\\\":\\\"PubMed\\\"}},{\\\"URL\\\":{\\\"$\\\":\\\"https://erepo.clinicalgenome.org/evrepo/ui/interpretation/a39fbdff-7b49-469e-8890-5baad55ff075\\\"}}]}}\",\"clingen_version\":0,\"submitted_assembly\":\"GRCh37\",\"submission_id\":\"506744.2019-02-27\",\"local_key\":\"a39fbdff-7b49-469e-8890-5baad55ff075\",\"clinical_assertion_observation_ids\":[\"SCV000840524.0\"],\"assertion_type\":\"variation to disease\",\"rcv_accession_id\":\"RCV000211722\",\"clinical_assertion_trait_set_id\":\"SCV000840524\",\"id\":\"SCV000840524\",\"submission_names\":[\"SUB5245899\"],\"record_status\":\"current\",\"date_created\":\"2018-10-18\",\"review_status\":\"reviewed by expert panel\",\"interpretation_date_last_evaluated\":\"2018-09-11\",\"version\":\"3\"}}",
  :genegraph.sink.stream/timestamp 1660859263168,
  :genegraph.sink.stream/topic "clinvar-raw",
  :genegraph.sink.stream/partition 0,
  :genegraph.sink.stream/offset 34044398,
  :genegraph.annotate/producer-topic :test-public-v1}
 {:genegraph.annotate/format :clinvar-raw,
  :genegraph.sink.event/key
  "clinical_assertion_SCV000198442_2021-07-07",
  :genegraph.sink.event/value
  "{\"release_date\":\"2021-07-07\",\"event_type\":\"update\",\"content\":{\"variation_id\":\"6241\",\"entity_type\":\"clinical_assertion\",\"variation_archive_id\":\"VCV000006241\",\"submitter_id\":\"21766\",\"date_last_updated\":\"2021-07-07\",\"interpretation_comments\":[\"{\\\"text\\\":\\\"The p.Gly285Ser variant in KCNQ4 has been reported in at least three individuals with hearing loss, and segregated with disease in over 15 affected relatives fr om two families (LMM unpublished data, Kubisch 1999, Wang 2014). It was absent f rom large population studies. In vitro functional studies support an impact on p rotein function and suggest that the variant may act in a dominant-negative mann er (Kubisch 1999, Bal 2008). Furthermore, the p.Gly285Ser variant falls within t he highly conserved pore-forming region of KCNQ4 (Oza 2018). Supporting the into lerance of this position to variation, a different amino acid change at the same position (p.Gly285Cys) has been reported in one family with hearing loss (Couck e 1999). Finally, this variant was classified as Pathogenic on 9/11/2018 by the ClinGen-approved Hearing Loss Expert Panel (Variation ID 6241). In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant no nsyndromic hearing loss. ACMG/AMP criteria applied: PP1_Strong, PM1, PM2, PP3, P S3_Supporting, PS4_Supporting.\\\"}\"],\"interpretation_description\":\"Pathogenic\",\"trait_set_id\":\"40993\",\"internal_id\":\"356389\",\"content\":\"{\\\"AttributeSet\\\":[{\\\"Attribute\\\":{\\\"$\\\":\\\"Autosomal dominant inheritance\\\",\\\"@Type\\\":\\\"ModeOfInheritance\\\"}},{\\\"Attribute\\\":{\\\"$\\\":\\\"LMM Criteria\\\",\\\"@Type\\\":\\\"AssertionMethod\\\"},\\\"Citation\\\":{\\\"ID\\\":{\\\"$\\\":\\\"24033266\\\",\\\"@Source\\\":\\\"PubMed\\\"}}}],\\\"Interpretation\\\":{\\\"Citation\\\":[{\\\"ID\\\":{\\\"$\\\":\\\"10025409\\\",\\\"@Source\\\":\\\"PubMed\\\"}},{\\\"ID\\\":{\\\"$\\\":\\\"18786918\\\",\\\"@Source\\\":\\\"PubMed\\\"}},{\\\"ID\\\":{\\\"$\\\":\\\"10369879\\\",\\\"@Source\\\":\\\"PubMed\\\"}},{\\\"ID\\\":{\\\"$\\\":\\\"30311386\\\",\\\"@Source\\\":\\\"PubMed\\\"}},{\\\"ID\\\":{\\\"$\\\":\\\"25116015\\\",\\\"@Source\\\":\\\"PubMed\\\"}}]}}\",\"clingen_version\":0,\"submitted_assembly\":\"GRCh37\",\"submission_id\":\"21766.2019-03-21\",\"local_key\":\"37462169|Orphanet:ORPHA96210\",\"clinical_assertion_observation_ids\":[\"SCV000198442.0\"],\"assertion_type\":\"variation to disease\",\"rcv_accession_id\":\"RCV000844633\",\"clinical_assertion_trait_set_id\":\"SCV000198442\",\"id\":\"SCV000198442\",\"submission_names\":[\"SUB5348977\"],\"record_status\":\"current\",\"date_created\":\"2015-01-28\",\"review_status\":\"criteria provided, single submitter\",\"interpretation_date_last_evaluated\":\"2018-10-23\",\"version\":\"4\"}}",
  :genegraph.sink.stream/timestamp 1660859842995,
  :genegraph.sink.stream/topic "clinvar-raw",
  :genegraph.sink.stream/partition 0,
  :genegraph.sink.stream/offset 37582457,
  :genegraph.annotate/producer-topic :test-public-v1}
 {:genegraph.annotate/format :clinvar-raw,
  :genegraph.sink.event/key
  "clinical_assertion_SCV000026802_2021-07-07",
  :genegraph.sink.event/value
  "{\"release_date\":\"2021-07-07\",\"event_type\":\"update\",\"content\":{\"variation_id\":\"6241\",\"entity_type\":\"clinical_assertion\",\"variation_archive_id\":\"VCV000006241\",\"submitter_id\":\"3\",\"date_last_updated\":\"2021-07-07\",\"interpretation_comments\":[],\"interpretation_description\":\"Pathogenic\",\"trait_set_id\":\"1730\",\"internal_id\":\"26802\",\"clingen_version\":0,\"submission_id\":\"3.2012-05-30\",\"local_key\":\"603537.0001_DEAFNESS, AUTOSOMAL DOMINANT 2A\",\"clinical_assertion_observation_ids\":[\"SCV000026802.0\"],\"title\":\"KCNQ4, GLY285SER_DEAFNESS, AUTOSOMAL DOMINANT 2A\",\"assertion_type\":\"variation to disease\",\"rcv_accession_id\":\"RCV000006619\",\"clinical_assertion_trait_set_id\":\"SCV000026802\",\"id\":\"SCV000026802\",\"submission_names\":[],\"record_status\":\"current\",\"date_created\":\"2011-01-25\",\"review_status\":\"no assertion criteria provided\",\"interpretation_date_last_evaluated\":\"2011-01-14\",\"version\":\"3\"}}",
  :genegraph.sink.stream/timestamp 1660859839596,
  :genegraph.sink.stream/topic "clinvar-raw",
  :genegraph.sink.stream/partition 0,
  :genegraph.sink.stream/offset 37547076,
  :genegraph.annotate/producer-topic :test-public-v1}
 {:genegraph.annotate/format :clinvar-raw,
  :genegraph.sink.event/key
  "clinical_assertion_SCV000041116_2021-07-07",
  :genegraph.sink.event/value
  "{\"release_date\":\"2021-07-07\",\"event_type\":\"update\",\"content\":{\"variation_id\":\"6241\",\"entity_type\":\"clinical_assertion\",\"variation_archive_id\":\"VCV000006241\",\"submitter_id\":\"500062\",\"date_last_updated\":\"2021-07-07\",\"interpretation_comments\":[],\"interpretation_description\":\"Pathogenic\",\"trait_set_id\":\"1730\",\"internal_id\":\"41116\",\"content\":\"{\\\"Interpretation\\\":{\\\"Citation\\\":[{\\\"ID\\\":{\\\"$\\\":\\\"10025409\\\",\\\"@Source\\\":\\\"PubMed\\\"}},{\\\"ID\\\":{\\\"$\\\":\\\"25116015\\\",\\\"@Source\\\":\\\"PubMed\\\"}},{\\\"URL\\\":{\\\"$\\\":\\\"http://www.ncbi.nlm.nih.gov/books/NBK1209/\\\"}}]}}\",\"clingen_version\":0,\"submission_id\":\"500062.2015-08-20\",\"local_key\":\"NM_004700.2:c.853G>A|OMIM:600101\",\"clinical_assertion_observation_ids\":[\"SCV000041116.0\"],\"assertion_type\":\"variation to disease\",\"rcv_accession_id\":\"RCV000006619\",\"clinical_assertion_trait_set_id\":\"SCV000041116\",\"id\":\"SCV000041116\",\"submission_names\":[],\"record_status\":\"current\",\"date_created\":\"2011-05-06\",\"review_status\":\"no assertion criteria provided\",\"interpretation_date_last_evaluated\":\"2015-08-20\",\"version\":\"1\"}}",
  :genegraph.sink.stream/timestamp 1660859839771,
  :genegraph.sink.stream/topic "clinvar-raw",
  :genegraph.sink.stream/partition 0,
  :genegraph.sink.stream/offset 37549407,
  :genegraph.annotate/producer-topic :test-public-v1}]
